Therapeutic Plasma Exchange Market Size, Share & Trends Analysis Report By Product & Technologies (Product (Consumables & Devices) And Technology (Centrifugation & Membrane Separation)), By Indication, By End-Users, Region And Segment Forecasts, 2025-2034

Report Id: 1120 Pages: 180 Last Updated: 18 June 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Therapeutic Plasma Exchange Market Segmentation:

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Product & Technology,

  • Product
    • Consumables
    • Devices
  • Technology
    • Centrifugation
    • Membrane Separation

Therapeutic Plasma Exchange Market

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), By Indication, 

  • Neurological Disorders: Guillain–Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Myasthenia gravis, Multiple sclerosis and PANDASa
  • Hematology Disorders: Thrombotic, thrombocytopenic purpura, Atypical haemolytic uraemic syndrome, Hyperviscosity syndromes and Severe/symptomatic cryoglobulinaemia
  • Renal Disorders: Goodpasture’s syndrome, Wegener’s glomerulonephritis and Antibody-mediated renal transplant rejection
  • Metabolic Disorders: Familial hypercholesterolaemia (homozygous)
  • Other Indications

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), By End Users, 

  • Blood Collection Centres & Blood Component Providers
  • Hospitals & Transfusion Centres
  • Other End Users

Global Therapeutic Plasma Exchange Market Revenue (US$ Mn), By Region, 

North America Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country,

  • U.S.
  • Canada

Europe Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country,

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country,

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country, 2019-2030

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Therapeutic Plasma Exchange Market Revenue (US$ Mn), by Country, 2019-2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Therapeutic Plasma Exchange Market Snapshot

Chapter 4. Global Therapeutic Plasma Exchange Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Penetration & Growth Prospect Mapping

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Products & Technology Advancement in Ambulatory Mammography

Chapter 5. Market Segmentation 1: Products & Technology Estimates & Trend Analysis

5.1. Products & Technology & Market Share, 2024 & 2034

5.2. Market Size (Value) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products & Technology:

5.2.1. Product

 Consumables

 Devices

5.2.2. Technology

 Centrifugation

 Membrane Separation

Chapter 6. Market Segmentation 1: Indications & Trend Analysis

6.1. Indications & Market Share, 2024 & 2034

6.2. Market Size (Value)& Forecasts and Trend Analyses, 2021 to 2034 for the following Indications:

6.2.1. Neurological Disorders

 Guillain–Barré syndrome

 Chronic inflammatory demyelinating polyneuropathy

 Myasthenia gravis

 Multiple sclerosis

 PANDASa

6.2.2. Hematology Disorders

 Thrombotic thrombocytopenic purpura

 Atypical haemolytic uraemic syndrome

 Hyperviscosity syndromes

 Severe/symptomatic cryoglobulinaemia

6.2.3. Renal Disorders

 Goodpasture’s syndrome

 Wegener’s glomerulonephritis

 Antibody-mediated renal transplant rejection

6.2.4. Metabolic Disorders

 Familial hypercholesterolaemia (homozygous)

6.2.5. Other Indications

Chapter 7. Market Segmentation 1: End-Users & Trend Analysis

7.1. End-Users & Market Share, 2024 & 2034

7.2. Market Size (Value)& Forecasts and Trend Analyses, 2021 to 2034 for the following End-Users

7.2.1. Blood Collection Centres & Blood Component Providers

7.2.2. Hospitals & Transfusion Centres

7.2.3. Other End Users

Chapter 8. Therapeutic Plasma Exchange Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts Products & Technology, 2021-2034

8.1.2. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034

8.1.3. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034

8.1.4. North America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by country, 2021-2034

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) Products & Technology, 2021-2034

8.2.2. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034

8.2.3. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034

8.2.4. Europe Therapeutic Plasma Exchange Market revenue (US$ Million) by country, 2021-2034

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) Products & Technology, 2021-2034

8.3.2. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034

8.3.3. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034

8.3.4. Asia Pacific Therapeutic Plasma Exchange Market revenue (US$ Million) by country, 2021-2034

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) Products & Technology, 2021-2034

8.4.2. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034

8.4.3. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034

8.4.4. Latin America Therapeutic Plasma Exchange Market revenue (US$ Million) by country, 2021-2034

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts Products & Technology, 2021-2034

8.5.2. MEA Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts by Indications, 2021-2034

8.5.3. MEA Therapeutic Plasma Exchange Market revenue (US$ Million) estimates and forecasts End-Users, 2021-2034

8.5.4. MEA revenue Therapeutic Plasma Exchange Market revenue (US$ Million) by country, (US$ Million) 2021-2034

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. TERUMO BCT, INC.

9.2.2. FRESENIUS SE & CO. KGAA

9.2.3. HAEMONETICS CORPORATION

9.2.4. BAXTER INTERNATIONAL INC.

9.2.5. ASAHI KASEI MEDICAL CO. LTD.

9.2.6. BRAUN MELSUNGEN AG

9.2.7. CERUS CORPORATION

9.2.8. KANEKA CORPORATION

9.2.9. KAWASUMI LABORATORIES, INC.

9.2.10. NIKKISO CO., LTD.

9.2.11. MILTENYI BIOTEC

9.2.12. Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1215
Security Code field cannot be blank!

Frequently Asked Questions

Therapeutic Plasma Exchange Market is expected to grow at an 5.5% CAGR during the forecast period for 2025-2034.

Terumo BCT, Inc., Fresenius SE & Co. KGaA, Haemonetics Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Ce

Product & Technologies, Indication and End-Users are the key segments of the Therapeutic Plasma Exchange Market.

North American region is leading the Therapeutic Plasma Exchange Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying